Evidence map›Paper›PMID 17138610›Full record

ReviewThe Journal of physiology2007

TRPpathies.

Kirill Kiselyov, Abigail Soyombo, Shmuel Muallem

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of physiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Measurement of Melanin Metabolism in Live Cells by [U-The Journal of investigative dermatology · 2021
    Article
  4. Review
  5. Review
  6. Gene expressions of TRP channels in glioblastoma multiforme and relation with survival.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  7. TRPV4 as a therapeutic target for joint diseases.Naunyn-Schmiedeberg's archives of pharmacology · 2015
    Review
  8. Article
  9. Article
  10. The Concise Guide to PHARMACOLOGY 2013/14: ion channels.British journal of pharmacology · 2013
    Article
  11. Article
  12. Orais and STIMs: physiological mechanisms and disease.Journal of cellular and molecular medicine · 2012
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Transient receptor potential channelopathies.Pflugers Archiv : European journal of physiology · 2010
    Review
  18. Review
  19. TRPMLs: in sickness and in health.American journal of physiology. Renal physiology · 2009
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kirill KiselyovDepartment of Biological Sciences, University of Pittsburgh, 4249 Fifth Avenue, Pittsburgh, PA 15260, USA. kiselyov@pitt.edu
Abigail Soyombo
Shmuel Muallem
Southwestern Medical Center · USUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many human diseases are caused by mutations in ion channels. Dissecting the pathogenesis of these 'channelopathies' has yielded important insights into the regulation of vital biological processes by ions and has become a productive tool of modern ion channel biology. One of the best examples of a synergism between the clinical and basic science aspects of a modern biological topic is cystic fibrosis. Not only did the identification of the ion channel mutated in cystic fibrosis pinpoint the root cause of this disease, but it also has significantly advanced our understanding of basic biological processes as diverse as protein folding and epithelial fluid and electrolyte secretion. The list of confirmed 'channelopathies' is growing and several members of the TRP family of ion channels have been implicated in human diseases such as mucolipidosis type IV (MLIV), autosomal dominant polycystic kidney disease (ADPKD), familial focal segmental glomerulosclerosis (FSG), hypomagnesemia with secondary hypocalcaemia (HSH), and several forms of cancer. Analysing pathogenesis of the diseases linked to TRP dysregulation provides an exciting means of identifying novel functions of TRP channels.

Indexed as

MutationAnimalsChannelopathiesGlomerulosclerosis, Focal SegmentalHumansMelanomaMiceMice, KnockoutMucolipidosesPolycystic Kidney, Autosomal DominantSkin NeoplasmsTransient Receptor Potential ChannelsTransient Receptor Potential Channels

Identifiers

PMID17138610
PMCPMC2151344
OpenAlexW3189729313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.